RevivBio, a trailblazing biotech company Redefining Biologics and Biosensors development, welcomes Dr. Ron Meeusen to its Board of Directors. Dr. Meeusen is a renowned leader in biotechnology, with a ...

Intellia Therapeutics’ stock may have taken a hit in the wake of details of a grade 4 adverse event in a phase 3 trial, but ...

Arrowhead Pharmaceuticals, Inc.'s deal with Sarepta expands its pipeline, but limited plozasiran market and competition ...

Calgary-based Cvictus, a clean energy and biotech startup, is poised to transform the way the world’s livestock is fed by providing a low-cost, low-carbon, sustainable alternative to fish or soybean ...

Goldman Sachs Global Healthcare Conference on Wednesday, June 11, 2025 at 2:40 p.m. ET ...

With Boster Bio's latest promotion, scientists globally enjoy free access to antibody validation to boost research accuracy.

Under the deal, announced on May 20, Pfizer gains the opportunity to develop and sell the SSGJ-707 drug in markets outside of ...

TIXiMED, Inc. ( a clinical-stage pharmaceutical company developing a novel disease-modifying oral therapy for type 1 diabetes (T1D), today announced the successful completion of the Phase 1 Single ...

One day, a dog named Scout might save your child’s life. It’s not a stretch. In fact, that possibility is fast becoming ...

The precision fermentation ingredients market is estimated to be USD 5.02 billion in 2025 and is projected to reach USD 36.31 ...

BioAgilytix officials say the company's expansion strengthens its ability to support biopharma partners at every stage of ...

BARCELONA — GLP-1 medications took center stage at Vitafoods Europe, held May 20 to 22 in Barcelona. Discussions at the show ...